doi: 10.1016/j.ejmech.2007.09.015.
Epub 2007 Sep 29.
Studies on novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents
Affiliations
- PMID: 17988764
- DOI: 10.1016/j.ejmech.2007.09.015
Item in Clipboard
Studies on novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents
Eur J Med Chem.
2008 Oct.
Abstract
A series of 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxin congeners have been designed and synthesized with significant regioselectivity by employing Cu(I) catalyzed 1,3-dipolar cycloaddition reaction of C4beta-azido podophyllotoxin and C4beta-azido-4'-O-demethyl podophyllotoxin with N-prop-2-yn-1-ylanilines. These compounds were evaluated for anticancer activity against a panel of seven human cancer cell lines. It was interesting to note that all the compounds exhibited promising activity especially against SF-295 (CNS), HCT-15 (colon) and 502713 (colon) cell lines. Compound 11e was found to be the most promising in this study.
Similar articles
-
Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.Arch Pharm (Weinheim). 2008 Feb;341(2):126-31. doi: 10.1002/ardp.200700116. Arch Pharm (Weinheim). 2008. PMID: 18214838
-
Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.Chem Biodivers. 2008 Sep;5(9):1792-802. doi: 10.1002/cbdv.200890168. Chem Biodivers. 2008. PMID: 18816530
-
4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.Eur J Med Chem. 2011 Jun;46(6):1983-91. doi: 10.1016/j.ejmech.2011.02.016. Epub 2011 Feb 24. Eur J Med Chem. 2011. PMID: 21477899
-
Recent Advances in the Application of Podophyllotoxin Derivatives to Fight Against Multidrug-Resistant Cancer Cells.Curr Top Med Chem. 2021;21(19):1712-1724. doi: 10.2174/1568026621666210113163327. Curr Top Med Chem. 2021. PMID: 33441065 Review.
-
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020).Eur J Med Chem. 2020 Dec 15;208:112830. doi: 10.1016/j.ejmech.2020.112830. Epub 2020 Sep 12. Eur J Med Chem. 2020. PMID: 32992133 Review.
Cited by
-
Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.Drug Des Devel Ther. 2018 Oct 9;12:3393-3406. doi: 10.2147/DDDT.S167382. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30349193 Free PMC article.
-
Ultrasound-Assisted Synthesis of Substituted Chalcone-Linked 1,2,3-Triazole Derivatives as Antiproliferative Agents: In Vitro Antitumor Activity and Molecular Docking Studies.Int J Mol Sci. 2025 Apr 4;26(7):3389. doi: 10.3390/ijms26073389. Int J Mol Sci. 2025. PMID: 40244239 Free PMC article.
-
Chemistry and Biological Activities of Naturally Occurring and Structurally Modified Podophyllotoxins.Molecules. 2022 Dec 30;28(1):302. doi: 10.3390/molecules28010302. Molecules. 2022. PMID: 36615496 Free PMC article. Review.
-
Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs.Front Cell Dev Biol. 2021 Aug 10;9:709075. doi: 10.3389/fcell.2021.709075. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34447752 Free PMC article. Review.
-
4-Des-oxy-4β-(4-methoxy-carbonyl-1,2,3-triazol-1-yl)podophyllotoxin dichloro-methane solvate.Acta Crystallogr Sect E Struct Rep Online. 2009 Nov 28;65(Pt 12):o3257. doi: 10.1107/S1600536809050612. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21578953 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
